Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBYOT.L Regulatory News (BYOT)

  • There is currently no data for BYOT

Directorate Change

4 Sep 2007 07:00

Byotrol PLC04 September 2007 4 September 2007 Byotrol plc ("Byotrol" or "the Company") Directorate change The Board of Byotrol is pleased to announce the appointment of Mr. Adrian J.R.Smith as Non-Executive Director of the Company with immediate effect. . Adrian Smith started his business career at Procter & Gamble Ltd in 1966 andserved 13 years in both sales and brand management positions. He also spent 11years at Ecolab Inc. in Europe and the United States as a senior internationalexecutive. He is currently the Chief Executive of The Woolton Group LLC, and isthe non-executive chairman of Gaming VC S.A. He is also a non-executive directorat Tutogen Inc. in Alachua, Florida. Before retiring from Deloitte ToucheTohmatsu in 2004, Adrian served as the CEO of Grant Thornton LLP and as aworldwide managing partner for marketing at Arthur Andersen from 1992 until1997. David McRobbie, Chief Executive Officer, commented "I am delighted to welcomeAdrian Smith to our board. His experience in certain of our target markets andhis varied business strengths will add to the quality of our Board" Adrian John Russell Smith, aged 62, holds or has held the followingdirectorships: Current Directorships & PartnershipsInvensco LLPWoolton Group LLCTutogen Inc.Gaming VC S.A.The Education Foundation of Indian River County Past Directorships & PartnershipsCarter & Carter Group plcHarbor Branch Oceanographic InstituteGrant Thornton LLPDeloitte & Touche LLPArthur Andersen LLP There are no other details required to be disclosed under paragraph (g) of Schedule 2 of the AIM Rules. For further information please contact: Byotrol plc 0161 277 9518Richard Bell, Finance Director 07825 204110 Charles Stanley Securities (Nominated Adviser) 020 7149 6000Philip Davies/Carl Holmes This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
30th Apr 20247:00 amRNSCancellation - Byotrol Plc
29th Apr 20242:15 pmRNSSecondary Trading on Asset Match
23rd Apr 20246:00 pmRNSByotrol
22nd Apr 20244:44 pmRNSCapital Reorganisation Delay
22nd Apr 20241:27 pmRNSResults of General Meeting
15th Apr 202411:48 amRNSHolding(s) in Company
8th Apr 20247:00 amRNSHolding(s) in Company
2nd Apr 20243:27 pmRNSDirector Dealing
28th Mar 20247:00 amRNSProposed Cancellation
22nd Dec 202311:44 amRNSHolding(s) in Company
7th Dec 20237:00 amRNSHalf-year Report
14th Nov 20237:00 amRNSLaunch of PROCESSUS® Instrument Decontamination
14th Nov 20237:00 amRNSTrading Update
9th Nov 20233:43 pmRNSHolding(s) in Company
27th Sep 20237:00 amRNSBoard Changes
13th Sep 20233:33 pmRNSResult of AGM
8th Sep 20234:33 pmRNSDirector Dealing
7th Sep 20237:01 amRNSBoard Appointment
7th Sep 20237:00 amRNSTrading Update
29th Aug 20238:51 amRNSLaunch of CHEMGENE MEDLAB into human healthcare
23rd Aug 20237:00 amRNSInvestor Presentation via Investor Meet Company
31st Jul 20237:00 amRNSFinal Results
6th Jul 20237:00 amRNSPatent Grant for Novel Anti-viral Seaweed Extract
24th May 20233:14 pmRNSUS EPA approves Byotrol24 as long-lasting virucide
24th May 20238:51 amRNSDirector Dealing
28th Apr 20239:57 amRNSDirector Dealing
27th Apr 20237:00 amRNSTrading Update and Board Changes
1st Feb 20239:52 amRNSDirector Dealing
22nd Dec 20223:08 pmRNSDirector Dealing
19th Dec 202210:00 amRNSDirector Dealing
16th Dec 20227:00 amRNSGrant of Share Incentive Awards
12th Dec 20227:00 amRNSInterim results and Investor Presentation
22nd Nov 20227:00 amRNSDirectorate Changes
27th Sep 202211:15 amRNSPDMR Shareholding
22nd Sep 20225:21 pmRNSResult of AGM
8th Sep 20227:00 amRNSDirector Dealing
2nd Sep 202210:02 amRNSInvestor Presentation
30th Aug 20227:00 amRNSFinal Results
12th Aug 20223:30 pmRNSDirector Dealing
28th Jul 20227:00 amRNSCompletion of Convertible Loan Note Fundraising
11th Jul 20227:00 amRNSTrading Update and Notice of Results
22nd Apr 20229:14 amRNSHolding(s) in Company
2nd Mar 20227:00 amRNSTrading Update
12th Jan 20227:00 amRNSSenior Management Appointment
14th Dec 20219:06 amRNSSecond Price Monitoring Extn
14th Dec 20219:00 amRNSPrice Monitoring Extension
13th Dec 20217:00 amRNSDirectorate Change
9th Dec 20218:51 amRNSDirector Dealing
8th Dec 20217:00 amRNSInterim Results and Investor Presentation
2nd Nov 20217:00 amRNSDirectorate and Senior Management Changes

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.